Santoro, Michele

Publishing since 2001 (Junior)

Has published 118 publications in 10 years

Number of publications published per year by Santoro, Michele. (Source : PubMed)

Distribution of publications types for Santoro, Michele. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Rusciano MR, Salzano M, Monaco S, Sapio MR, Illario M, De Falco V, Santoro M, Campiglia P, Pastore L, Fenzi G, Rossi G, Vitale M. The Ca2+-calmodulin-dependent kinase II is activated in papillary thyroid carcinoma (PTC) and mediates cell proliferation stimulated by RET/PTC.  Endocr. Relat. Cancer  2010;17;1  
•  Scarpellini E, Valenza V, Gabrielli M, Lauritano EC, Perotti G, Merra G, Dal Lago A, Ojetti V, Ainora ME, Santoro M, Ghirlanda G, Gasbarrini A. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?  Am. J. Gastroenterol.  2010;105;2  
•  Salerno P, De Falco V, Tamburrino A, Nappi TC, Vecchio G, Schweppe RE, Bollag G, Santoro M, Salvatore G. Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells.  J. Clin. Endocrinol. Metab.  2010;95;1  
•  Castellone MD, Verrienti A, Rao DM, Sponziello M, Fabbro D, Muthu M, Durante C, Maranghi M, Damante G, Pizzolitto S, Costante G, Russo D, Santoro M, Filetti S. A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization.  Clin. Endocrinol. (Oxf)  2009  
•  Colloca G, Santoro M, Gambassi G. Age-related physiologic changes and perioperative management of elderly patients.  Surg Oncol  2009  
•  Wells SA, Santoro M. Targeting the RET pathway in thyroid cancer.  Clin. Cancer Res.  2009;15;23  
•  Mancini M, Vergara E, Salvatore G, Greco A, Troncone G, Affuso A, Liuzzi R, Salerno P, Scotto di Santolo M, Santoro M, Brunetti A, Salvatore M. Morphological ultrasound microimaging of thyroid in living mice.  Endocrinology  2009;150;10  
•  Fedele M, Palmieri D, Chiappetta G, Pasquinelli R, De Martino I, Arra C, Palma G, Valentino T, Pierantoni GM, Viglietto G, Rothstein JL, Santoro M, Fusco A. Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice.  Endocr. Relat. Cancer  2009;16;2  
•  Nappi TC, Salerno P, Zitzelsberger H, Carlomagno F, Salvatore G, Santoro M. Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma.  Cancer Res.  2009;69;5  
•  Castellone MD, De Falco V, Rao DM, Bellelli R, Muthu M, Basolo F, Fusco A, Gutkind JS, Santoro M. The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation.  Cancer Res.  2009;69;5  

[ See timeline ] [ See all publications ]